INDUSTRY BUZZ

Earnings Report: Top Payers Announce Q3 Earnings

The country's five largest commercial payers posted strong results for the third quarter of fiscal year 2018:. COMPANY QUARTERLY REVENUES PERFORMANCE Total Q3* 2018 YOY Wall … [Read more...]

CUSTOMER SERVICE

Lab Leaders Have New Opportunities in the Age of Consumerism

The G2 Power Panel provided attendees at the 36th annual Lab Institute (Oct. 24-26; Washington, D.C.) an opportunity to learn how some of the nation's leading laboratories are navigating the current … [Read more...]

REVENUES

DX Earnings Report: Q2 Lab Earnings Stay Strong but Not Quite at Q1 Levels

Q2 is shaping up to be another strong quarter—albeit not as stellar as Q1. Salient trends: Big labs continue posting impressive organic growth even as they enjoy the surge of new revenues from … [Read more...]

SPECIAL FOCUS

Cost Avoidance vs Cost Savings: What’s the Difference?

By Jennifer Dawson, MHA, DLM (ASCP)  bio As I work to spread awareness within the clinical laboratory community about the Cost of Poor Quality (COPQ) concept and its benefits as a method to … [Read more...]

EARNINGS

How to Avoid a Laboratory Audit

By Sean McSweeney  bio Laboratory audits have a much harder impact on your lab than intended. As detailed by the NCBI, the audit's intent is to review and assess laboratory performance to … [Read more...]

PAMA

PAMA Unlocks Golden Age for Innovative Diagnostics

By Chance Scott  bio The publication of the 2018 Clinical Laboratory Fee Schedule (CLFS) in January saw a long and heated debate within the lab community come to fruition. When Congress … [Read more...]

REVENUES

DX Earnings Report: PAMA Cuts Make Little Dent on Q1 Lab Earnings

One quarter into its existence, the new PAMA Medicare Part B fee schedule seems to be having only a marginal impact on at least publicly traded labs. In fact, the recently published Q1 earnings … [Read more...]

REVENUES

Dx Earnings Report: Strong Q4 as Lab Companies End Year with a Bang

Big PAMA cuts may lay ahead in 2017, but the diagnostics industry had a robust 2017. While the entire year was strong, success was the most widespread in the fourth quarter with all but a few … [Read more...]

REVENUES

Dx Earnings Report: Strong Q3 Adds to Robust 2017 as PAMA Looms for 2018

Big labs continue to post impressive earnings. But the positive Q3 numbers may prove to be the calm before the PAMA storm—at least for major reference labs that generate significant revenues from … [Read more...]

EARNINGS REPORTS

Dx Earnings Report: Strong Q2 Enables Lab Companies to Consolidate Q1 Gains

The lab industry consolidated its early 2017 gains with an almost equally strong Q2. Although there were some notable declines, most companies posted gains at or above Wall Street expectations. Here's … [Read more...]


(-00000g2)